Treatment of Deep Vein Thrombosis and Pulmonary Embolism in Pregnancy

dc.contributor.author	Gargoum, Aya Mohammed
dc.date.accessioned	2019-02-02T11:22:08Z
dc.date.available	2019-02-02T11:22:08Z
dc.date.issued	2018-05-05
dc.identifier.uri	http://repository.limu.edu.ly/handle/123456789/424
dc.description	Pregnancy and the puerperium are well-established risk factors for deep vein thrombosis (DVT) and pulmonary embolism (PE), which are collectively referred to as venous thromboembolic disease (VTE). The venous thromboembolic disease can manifest during pregnancy as an isolated lower extremity deep vein thrombosis (DVT) or clot can break off from the lower extremities and travel to the lung to present as a pulmonary embolus (PE). PE is the seventh leading cause of maternal mortality, responsible for 9 percent of maternal deaths. Thus, the detection of DVT during pregnancy is critical to preventing deaths from PE. Although most reports suggest that VTE can occur at any trimester in pregnancy, studies suggest that VTE is more common during the first half of pregnancy. The Treatment of VTE during pregnancy and the puerperium will be reviewed here	en_US
dc.language.iso	en	en_US
dc.publisher	faculty of Basic Medical Science - Libyan International Medical University	en_US
dc.rights	Attribution 3.0 United States	*
dc.rights.uri	http://creativecommons.org/licenses/by/3.0/us/	*
dc.title	Treatment of Deep Vein Thrombosis and Pulmonary Embolism in Pregnancy	en_US
dc.type	Other	en_US

Except where otherwise noted, this item's license is described as Attribution 3.0 United States